Artelo Biosciences (NASDAQ:ARTL) is expanding its development pipeline into ophthalmology with a new clinical study evaluating its drug candidate ART27.13 for the treatment of glaucoma. The San ...

Investigator-sponsored study funded by Glaucoma UK and the HSC R&D Division expands ART27.13’s clinical potential into ophthalmologyFirst ...

The 2026 Shaffer Research Grants were awarded to Kun-Che Chang, PhD, Shruthi Karnam, PhD, Kate Keller, PhD, Naoki Kiyota, MD, PhD, Gillian McLellan, PhD, Kiyoharu Miyagishima, PhD, Kerstin Nundel, PhD ...

When the eye's drainage system clogs, pressure builds up and causes damage. The pressure can lead to glaucoma and vision loss. New research, published in the journal Immunity, reveals that a ...

Explore the latest research on glaucoma treatment and the role of immune cells in eye pressure regulation for better outcomes ...

New English and Spanish editions of Understanding and Living with Glaucoma and first-ever Spanish audiobook aim to reach high-risk Hispanic ...

Artelo Biosciences (ARTL) stock jumped 40% after announcing a fully-funded glaucoma trial for ART27.13 with Belfast Health and Social Care Trust.

Glaucoma Research Foundation, a national non-profit organization dedicated to finding a cure for glaucoma, today announced a team of neuroscience researchers, led by Adriana Di Polo, PhD, at ...

Genomics can help to identify people who are more likely to develop glaucoma potentially long before any symptoms of the disease appear. Instead ...

A new center coming to UC San Diego, funded by a $20 million donation from philanthropists Hanna and Mark Gleiberman, has its sights set on discovering how to reverse glaucoma. The Hanna and Mark ...

Since 1978, the Glaucoma Research Foundation (glaucoma.org) has funded innovative research into better treatments and an eventual cure for glaucoma, a group of eye disorders that accounts for up to 12 ...

Please provide your email address to receive an email when new articles are posted on . By 2040, worldwide cases of glaucoma are expected to increase 74%, but the potential for artificial intelligence ...